Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 50201-50250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05384353
In Vivo PET of Synaptic Density in Cognitive Disorders
N/ARecruiting
150 participants
Started: Apr 11, 2022 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT06111430
Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer
N/ARecruiting
800 participants
Started: Apr 11, 2022 · Completed: Apr 10, 2026
2 conditions1 sponsor1 location
NCT05091866
Natural Progesterone for the Treatment of Recurrent Glioblastoma
EARLY_PHASE1Recruiting
32 participants
Started: Apr 11, 2022 · Completed: Aug 25, 2026
2 conditions2 sponsors1 location
NCT05390749
Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL
PHASE2Recruiting
50 participants
Started: Apr 11, 2022 · Completed: Apr 1, 2026
1 condition3 sponsors3 locations
NCT05101174
Exercise and Neurocognition in Adults Relative to ApoE Genotype
NARecruiting
120 participants
Started: Apr 11, 2022 · Completed: Sep 30, 2025
3 conditions1 sponsor2 locations
NCT05332444
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
PHASE4Recruiting
450 participants
Started: Apr 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05071898
Pharmacogenetics of Response to GLP1R Agonists
PHASE1Recruiting
600 participants
Started: Apr 11, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06273956
Explore the Relationship Between Platelet Count and Bleeding Score in ITP
N/ARecruiting
100 participants
Started: Apr 10, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05365009
Registry of Autoimmune Interstitial Lung Disease
N/ARecruiting
1,000 participants
Started: Apr 10, 2022 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT05325528
Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
PHASE2/PHASE3Recruiting
40 participants
Started: Apr 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05573997
Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure
N/ARecruiting
300 participants
Started: Apr 10, 2022 · Completed: Jan 10, 2025
4 conditions1 sponsor1 location
NCT05383638
Effectiveness of Health Promotion Interventions in Improving Patient Satisfaction
NARecruiting
350 participants
Started: Apr 10, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05327517
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NARecruiting
192 participants
Started: Apr 10, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05345132
Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs
NARecruiting
264 participants
Started: Apr 10, 2022 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT05185115
Efficacy of Nasal Oxygen Therapy to Reduce Postoperative Complications in Ankle Trauma Surgery in At-risk Patients: a Randomized Pilot Study.
PHASE3Recruiting
200 participants
Started: Apr 9, 2022 · Completed: Oct 1, 2026
1 condition2 sponsors1 location
NCT05368571
CHOICES-TEEN Randomized Controlled Trial
NARecruiting
400 participants
Started: Apr 8, 2022 · Completed: Apr 10, 2026
5 conditions2 sponsors1 location
NCT05190653
Early Integration of Palliative and Supportive Care in Cellular Therapy
NARecruiting
152 participants
Started: Apr 8, 2022 · Completed: Dec 31, 2025
6 conditions3 sponsors1 location
NCT04252950
Community-based Exercise Following Revascularization for PAD
NARecruiting
30 participants
Started: Apr 8, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05306912
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
NARecruiting
60 participants
Started: Apr 8, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05318534
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease
PHASE1Recruiting
70 participants
Started: Apr 8, 2022 · Completed: Jan 21, 2026
1 condition1 sponsor1 location
NCT05388695
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
PHASE1Recruiting
100 participants
Started: Apr 8, 2022 · Completed: May 30, 2027
2 conditions2 sponsors1 location
NCT06135844
Hand Sanitizer Use for Herpes Simplex Virus-1
EARLY_PHASE1Recruiting
20 participants
Started: Apr 8, 2022 · Completed: Nov 30, 2023
4 conditions1 sponsor3 locations
NCT05283265
Neurophysiological Mechanisms of Language Comprehension
NARecruiting
153 participants
Started: Apr 8, 2022 · Completed: Oct 8, 2026
1 condition2 sponsors1 location
NCT05306548
A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome
PHASE4Recruiting
258 participants
Started: Apr 8, 2022 · Completed: Mar 31, 2028
1 condition5 sponsors5 locations
NCT05271344
Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion.
NARecruiting
74 participants
Started: Apr 8, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05195385
Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study
NARecruiting
2,635 participants
Started: Apr 8, 2022 · Completed: Oct 8, 2027
1 condition3 sponsors1 location
NCT05448846
Exercise Program for Colorectal Older Patients
NARecruiting
252 participants
Started: Apr 8, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05395962
Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
PHASE2Recruiting
92 participants
Started: Apr 8, 2022 · Completed: Apr 7, 2027
1 condition1 sponsor1 location
NCT05288543
A Study of Orally Administered IPG7236 in Healthy Adult Participants
PHASE1Recruiting
62 participants
Started: Apr 8, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06363058
Electrical Stimulation Cycling Training Effects on SCA
NARecruiting
145 participants
Started: Apr 8, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05329532
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
PHASE1/PHASE2Recruiting
168 participants
Started: Apr 7, 2022 · Completed: Jul 1, 2027
4 conditions1 sponsor16 locations
NCT04735172
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
NARecruiting
44 participants
Started: Apr 7, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor2 locations
NCT05076110
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
PHASE4Recruiting
188 participants
Started: Apr 7, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05304286
Psychophysical and Neural Mechanisms Contributing to Chronic Post-Surgical Pain in Adolescents and Adults
NARecruiting
110 participants
Started: Apr 7, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06228014
Pilot Study: AI Algorithm for Dermatology Referral Optimization
N/ARecruiting
200 participants
Started: Apr 7, 2022 · Completed: Dec 30, 2024
2 conditions4 sponsors1 location
NCT04681573
Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD
NARecruiting
1,045 participants
Started: Apr 7, 2022 · Completed: Dec 7, 2028
1 condition1 sponsor15 locations
NCT05427838
Simulation Training in Emergency Department Imaging 2
N/ARecruiting
294 participants
Started: Apr 7, 2022 · Completed: Jun 30, 2026
5 conditions1 sponsor6 locations
NCT05394467
Adipose Cellular Kinetics of Lipedema
N/ARecruiting
24 participants
Started: Apr 7, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05319873
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
PHASE1/PHASE2Recruiting
18 participants
Started: Apr 7, 2022 · Completed: Apr 1, 2027
20 conditions3 sponsors1 location
NCT05200182
fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating
NARecruiting
80 participants
Started: Apr 7, 2022 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT05316181
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
PHASE3Recruiting
140 participants
Started: Apr 7, 2022 · Completed: Dec 31, 2029
6 conditions1 sponsor3 locations
NCT06054386
Attention Bias Modification Training for Social Phobia (ABMSP)
NARecruiting
60 participants
Started: Apr 7, 2022 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT04968899
IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
PHASE3Recruiting
272 participants
Started: Apr 7, 2022 · Completed: Oct 9, 2026
1 condition1 sponsor1 location
NCT05145361
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
EARLY_PHASE1Recruiting
45 participants
Started: Apr 7, 2022 · Completed: Dec 15, 2025
1 condition1 sponsor4 locations
NCT05427383
KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
PHASE2/PHASE3Recruiting
286 participants
Started: Apr 7, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05212766
Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease
N/ARecruiting
750 participants
Started: Apr 7, 2022 · Completed: Dec 30, 2024
6 conditions3 sponsors1 location
NCT05309876
Secondary Prevention With the Lifestyle Tool
NARecruiting
11,000 participants
Started: Apr 6, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05438563
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
NARecruiting
100 participants
Started: Apr 6, 2022 · Completed: Mar 7, 2027
3 conditions1 sponsor1 location
NCT05104736
PT-112 in Subjects With Thymoma and Thymic Carcinoma
PHASE2Recruiting
53 participants
Started: Apr 6, 2022 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT05109494
Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas
PHASE2Recruiting
30 participants
Started: Apr 6, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location